Status:
COMPLETED
Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The major goal of this project is to reduce unnecessary pancreatic resections, namely resection in those patients with non-regional lymph node metastatses that cannot be cured with surgical resection....
Eligibility Criteria
Inclusion
- Patients with a mass in the pancreas suspicious for adenocarcinoma without biopsy proven distant metastases.
- Patients who are scheduled for clinically indicated EUS
Exclusion
- Patients who are medically unfit for endoscopic sedation or surgery due to severe comorbid disease such as uncontrolled coronary disease, or oxygen dependant pulmonary disease.
- Patients who have any other malignancy other than basal cell carcinoma within the past 5 years.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00826982
Start Date
January 1 2008
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224